A Phase 1 Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics After Administration of Fixed-dose Combination of DW6013 and Loose Combination of Each Component in Healthy Adult Volunteers in Fast Condition
Latest Information Update: 30 May 2023
At a glance
- Drugs Linagliptin/metformin (Primary) ; Linagliptin; Metformin
- Indications Diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Dong Wha Pharmaceutical
Most Recent Events
- 30 May 2023 New trial record